Which pharmacologic option is listed as strongly against use in all forms of OA aside from TNFi?

Which pharmacologic option is listed as strongly against use in all forms of OA aside from TNFi?

• A. Hydroxychloroquine
• B. Bisphosphonates
• C. Methotrexate
• D. IL-1 receptor antagonist

Answer: (A)

In osteoarthritis, the aim is to relieve symptoms and improve function, but most immunomodulatory drugs that work in autoimmune diseases don’t help OA. Hydroxychloroquine is singled out as strongly against in OA because trials consistently show no meaningful improvement in pain or function with its use in OA, and it carries potential toxicities such as retinal damage. The idea behind excluding it is that OA is not driven by the autoimmune processes these drugs target, so they don’t alter the disease course, whereas TNF inhibitors may be considered in inflammatory arthritides that can coexist with OA but are not standard for OA itself. So hydroxychloroquine is avoided due to lack of efficacy and risk, making it the best answer in this context.

In osteoarthritis, the aim is to relieve symptoms and improve function, but most immunomodulatory drugs that work in autoimmune diseases don’t help OA. Hydroxychloroquine is singled out as strongly against in OA because trials consistently show no meaningful improvement in pain or function with its use in OA, and it carries potential toxicities such as retinal damage. The idea behind excluding it is that OA is not driven by the autoimmune processes these drugs target, so they don’t alter the disease course, whereas TNF inhibitors may be considered in inflammatory arthritides that can coexist with OA but are not standard for OA itself. So hydroxychloroquine is avoided due to lack of efficacy and risk, making it the best answer in this context.